The Valley Desk

NCT06846320 · Interventional trial

Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder

Overall registry status Recruiting

Phase 2

Conditions Generalized Anxiety Disorder (GAD)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov